From: The establishment of a bank of stored clinical bone marrow stromal cell products
Donor | Aspirated Marrow | ||||||||
---|---|---|---|---|---|---|---|---|---|
 | Age (years) |  |  | Volume* (mL) | TNC (106) | CD34 | CD3 | ||
Number | Â | Gender | Race | Â | Â | (%) | #(106) | % | # |
1 | 35.6 | M | AA | 21 | 165 | 2.26 | 3.73 | 10.7 | 17.7 |
2 | 22.9 | M | W | 26 | 266 | 1.56 | 4.15 | 11.7 | 31.1 |
3 | 22.8 | F | W | 27.5 | 374 | 1.20 | 4.48 | 13.3 | 49.7 |
4 | 67.9 | F | W | 27 | 127 | 0.71 | 0.90 | 5.19 | 6.59 |
5 | 21.7 | M | W | 25 | 584 | 0.66 | 3.85 | 7.62 | 44.5 |
6†| 49.5 | M | W | vCJD risk | NA | NA | NA | NA | NA |
7 | 23.7 | F | W | 24.8 | 788 | 1.71 | 13.5 | 6.89 | 54.3 |
8†| 52.1 | M | W | + TTD test | NA | NA | NA | NA | NA |
9†| 31.5 | F | AA | Low Hgb | NA | NA | NA | NA | NA |
10 | 27.2 | M | AA | 27 | 681 | 1.44 | 1.44 | 6.81 | 46.4 |
11 | 56.8 | M | W | 26 | 228 | 1.4 | 3.19 | 9.38 | 21.4 |
12†| 24.9 | F | W | Sick | NA | NA | NA | NA | NA |
13†| 26.6 | F | AA | TTD risk | NA | NA | NA | NA | NA |
1ŧ | 36.5 | M | AA | 25.6 | 153 | 1.99 | 3.04 | 10.4 | 15.9 |
14 | 21.3 | M | AA | 27 | 271 | 1.45 | 3.93 | 13.5 | 36.6 |
15 | 59.4 | M | W | 25 | 160 | 0.45 | 0.72 | 8.67 | 13.9 |
16 | 25.2 | F | W | +CMV IgM | NA | NA | NA | NA | NA |
17†| 30.8 | F | A | Elev. PTT | NA | NA | NA | NA | NA |